This is the fundraising page for my class for our school's color run fundraiser. Want to help my class get a donation from every state in the United States....?
https://t.co/U5GkDVRluM
Lately, there have been many little monsters in my head. But their biggest enemy is rainbows in the rain. So I continue to search for those rainbows every day because those little monsters will never win.
!!!!!!!!!!!!! @JNJNews, THANK YOU for choosing #PatientsNotPatents. Takes real guts to live up to your credo. Generic bedaquiline WILL BE AVAILABLE in almost every country with a high tuberculosis burden. I am so happy and grateful to the Stop TB Partnership, J&J, and especially the activists around the world who are standing up for TB patients. So much more work to do, but WHAT WONDERFUL NEWS TO WAKE UP TO.
10M diagnosed per year. 1.5M die per year.
660k over 20 years is 33k average per year.
33k of 10M is 0.33% of all cases in one year.
Big numbers doesn't always mean big things, J&J #PatientsNotPatents
It is false to suggest—as some recently have—that our patents are being used to prevent access to SIRTURO® (bedaquiline), our medicine for MDR-TB.
In fact, we have already entered into a collaboration with the Stop TB Partnership’s Global Drug Facility (“GDF”)—the largest procurer of TB medicines—which enables them to invite potential generic suppliers and purchase generic versions of SIRTURO® 100mg. On April 5, during a World Health Organization meeting, the GDF shared its intent to launch a tender for generic versions of SIRTURO® 100mg in the third quarter of 2023: https://t.co/6m49h5g7tn
In addition, we have shipped more than 660,000 courses of SIRTURO® to 159 countries since launch. Our patents made this possible, enabling us to assist countries to scale-up their use of our medicine responsibly and sustainably and invest in multiple, critical, anti-TB efforts. For instance, in the face of rising drug resistance, we support stewardship efforts that ensure MDR-TB patients can benefit from our medicine today and in the future.
Unfortunately, the most significant barrier to treatment access for patients today is the fact that millions of patients with TB go undiagnosed every year. This is a challenge that we have invested significant resources to overcome and must all get behind if we are to achieve the global goal of ending TB.
What J&J has to understand is that John has spent a full year making Tuberculosis /his thing/ in a way that has been clearly a net negative for the amount of attention he receives but a huge net positive for the amount of attention TB receives.
This isn't some whim.
@sportswithjohn And they fell badly into the red flag of turning off replies. They want this to pass. But it won't because we recognize the importance of it.
Lessons in Chemistry by Bonnie Garmus. One of the best books I've read in a long time. Words cannot even begin to to describe how well written of a story it is and how much it spoke to me. Read it if you can.
Today was one of those days where I began to think about how much my life has changed in the past few years. Two years ago, I was interviewing for teaching positions.
To say leaving my old job to be a teacher was the best thing ever still feels like an understaement.
We will be giving away ONE (1) ticket to the Eras Tour Detroit for 6/9 TODAY! Retweet this for your chance to enter, ends at 1 PM EST TODAY!!!!!✨ #TSTheErasTour#DetroitTSTheErasTour
We will be giving away ONE (1) ticket to the Eras Tour Detroit for 6/9 TOMORROW. Retweet this for your chance to enter, ends at 9am EST tomorrow✨ #TSTheErasTour#DetroitTSTheErasTour
One day I will learn how to better time writing papers so I don't leave them to the last minute. It isn't as bad as I have been in the past. But I am vibing at procrastination station.
@turini2@alysjones96 After looking it up, I do think the vinegar content might be slightly off putting. But I also know my taste bud preferences have been highly judged before.